[{"Assets_0_Q3_USD":249170000.0,"CommonStockSharesOutstanding_0_Q3_shares":36085266.0,"NetIncomeLoss_1_Q3_USD":-15356000.0,"NetIncomeLoss_3_Q3_USD":-43580000.0,"StockholdersEquity_0_Q3_USD":175847000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20171031"}]